Identification and characterization of recombinant murine interleukin-6 with a C-terminal pentapeptide extension using capillary reversed phase HPLC-MS and edman degradation

Biomed Chromatogr. 1997 Nov-Dec;11(6):337-42. doi: 10.1002/(SICI)1099-0801(199711)11:6<337::AID-BMC687>3.0.CO;2-E.

Abstract

We have identified a preparation of recombinant murine interleukin-6 (mIL-6) that, in addition to the anticipated product, also contained approximately equal amounts of mIL-6 with a C-terminal pentapeptide extension. The extension mutant was generated by readthrough of the stopcodon, and termination at a second in-frame stopcodon 12 base pairs 3' in the expression vector. Aliquots of the preparation were subjected to proteolytic digestion with Asp-N and Lys-C-endopeptidase. The resultant peptides were separated by reversed-phase capillary HPLC, and analysed using a combination of mass spectrometry and N-terminal sequence analysis. These data revealed a C-terminal pentapeptide (Gln-Gly-Ser-Val-Asp) extension, with the authentic stopcodon being translated as glutamine. The extension mutant was isolated by reversed-phase HPLC and shown to have similar mitogenic activity to mIL-6 on murine hybridoma 7TD1 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chromatography, High Pressure Liquid / methods*
  • Interleukin-6 / chemistry*
  • Interleukin-6 / pharmacology
  • Mass Spectrometry / methods*
  • Mice
  • Mitogens / pharmacology
  • Oligopeptides / chemistry*
  • Peptide Mapping / methods
  • Protein Conformation
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / pharmacology

Substances

  • Interleukin-6
  • Mitogens
  • Oligopeptides
  • Recombinant Proteins